All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ELEVATION ONCOLOGY, INC. Last Reported: 2/29/2024 Stock Symbol: ELEV

Business Address

101 FEDERAL STREET
SUITE 1900
BOSTON , MA US 02110

Mailing Address

101 FEDERAL STREET
SUITE 1900
BOSTON , MA US 02110
Phone Number: 716-371-1125 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Cash and Cash Equivalents $54,878,000.00 $106,325,000.00 $55,902,000.00 $45,917,000.00 $52,589,000.00 $53,882,000.00 $53,008,000.00 $146,284,000.00 $155,200,000.00 $158,000,000.00 -- $79,400,000.00 -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $4,000,000.00 $1,502,000.00 $1,906,000.00 $2,697,000.00 $2,215,000.00 $1,143,000.00 $2,187,000.00 $3,140,000.00 $3,237,000.00 $933,000.00 -- $1,386,000.00 -- -- -- --
Total Current Assets $98,797,000.00 $109,425,000.00 $75,835,000.00 $92,977,000.00 $110,074,000.00 $123,685,000.00 $134,249,000.00 $149,424,000.00 $158,435,000.00 $158,950,000.00 -- $80,786,000.00 -- -- -- --
Property Plant and Equipement $68,000.00 $78,000.00 $88,000.00 $98,000.00 $108,000.00 $30,000.00 $34,000.00 $38,000.00 $43,000.00 $47,000.00 -- $56,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $1,110,000.00 $867,000.00 $975,000.00 $1,086,000.00 $1,310,000.00 $67,000.00 $25,000.00 $32,000.00 $40,000.00 $65,000.00 -- $65,000.00 -- -- -- --
Total Assets $99,975,000.00 $110,370,000.00 $76,898,000.00 $94,161,000.00 $111,492,000.00 $123,782,000.00 $134,308,000.00 $149,494,000.00 $158,518,000.00 $159,062,000.00 -- $80,907,000.00 -- -- -- --
Accounts Payable $3,640,000.00 $5,241,000.00 $4,043,000.00 $6,362,000.00 $5,665,000.00 $1,296,000.00 $882,000.00 $5,648,000.00 $5,435,000.00 $939,000.00 -- $5,679,000.00 -- -- -- --
Accrued Liabilities $3,967,000.00 $3,176,000.00 $9,491,000.00 $9,330,000.00 $9,435,000.00 $17,798,000.00 $9,553,000.00 $3,141,000.00 $3,445,000.00 $2,774,000.00 -- $1,106,000.00 -- -- -- --
Total Current Liabilities $37,559,000.00 $38,189,000.00 $43,134,000.00 $45,129,000.00 $44,371,000.00 $19,099,000.00 $10,442,000.00 $8,797,000.00 $8,890,000.00 $3,725,000.00 -- $6,800,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-1,000.00 $-2,000.00 $-51,000.00 $-161,000.00 $-258,000.00 $-275,000.00 $-204,000.00 -- -- -- -- -- -- -- -- --
Accumulated Deficit $-188,071,000.00 $-177,400,000.00 $-167,325,000.00 $-150,266,000.00 $-131,224,000.00 $-92,400,000.00 $-72,500,000.00 $-55,186,000.00 $-45,564,000.00 $-33,297,000.00 -- $-23,147,000.00 -- -- -- --
Total Stockholders' Equity $62,416,000.00 $72,181,000.00 $33,764,000.00 $49,032,000.00 $67,121,000.00 $104,683,000.00 $123,866,000.00 $140,697,000.00 $149,628,000.00 $155,337,000.00 $-28,105,000.00 $-23,081,000.00 $-14,208,000.00 $-11,213,000.00 $-7,822,000.00 $-5,873,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $99,975,000.00 $110,370,000.00 $76,898,000.00 $94,161,000.00 $111,492,000.00 $123,782,000.00 $134,308,000.00 $149,494,000.00 $158,518,000.00 $159,062,000.00 -- $80,907,000.00 -- -- -- --

Statement of Operations

Date 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $20,743,000.00 $13,321,000.00 $7,292,000.00 $78,717,000.00 $64,215,000.00 $16,300,000.00 $13,575,000.00 $23,595,000.00 $17,346,000.00 $8,048,000.00 -- -- $7,042,000.00 $4,492,000.00 -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $37,499,000.00 $9,834,000.00 $16,745,000.00 $94,549,000.00 $38,531,000.00 $37,481,000.00 $17,368,000.00 $32,046,000.00 $12,277,000.00 $10,145,000.00 -- -- $8,389,000.00 $5,377,000.00 -- --
Loss from Operations $-37,499,000.00 $-9,834,000.00 $-16,745,000.00 $-94,549,000.00 $-76,012,000.00 $-20,113,000.00 $-17,368,000.00 $-32,046,000.00 $-12,277,000.00 $-10,145,000.00 -- -- $-8,389,000.00 $-5,377,000.00 -- --
Loss Before Income Taxes $-10,625,000.00 $-10,105,000.00 $-17,054,000.00 $-95,055,000.00 -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.25 $-1.06 $-0.72 $-4.09 $-3.27 $-1.60 $-0.74 $-2.64 $-2.67 $-10.98 -- -- $-3.80 $-6.80 -- --
Weighted Average Shares Basic 42,402,489 25,608,008 23,618,559 23,267,120 23,255,343 23,237,600 23,216,206 12,132,610 8,402,277 924,131 -- -- 790,175 788,846 -- --
Earnings Per Share Diluted $-1.21 $-1.06 $-0.72 $-4.09 $-1.67 $-1.60 $-0.74 $-2.64 $-0.53 $-10.98 -- -- $-10.60 $-6.80 -- --
Weighted Average Shares Diluted 42,402,489 27,575,596 23,618,559 23,267,120 23,290,249 23,237,600 23,216,206 12,132,610 23,114,715 924,131 -- -- 790,175 788,846 -- --
Common Stock Shares Authorized 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 -- 86,000,000 -- -- -- --
Common Stock Shares Outstanding 42,414,741 42,381,952 23,786,337 23,312,529 23,300,796 23,289,064 23,253,966 23,205,915 23,201,971 22,794,620 -- 800,679 -- -- -- --
Common Stock Value $4,000.00 $4,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00 -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com